TY - JOUR AU - Fabrizi, F. AU - Martin, P. AU - Dixit, V. AU - Messa, P. PY - 2014 DA - 2014// TI - Meta-analysis of observational studies: hepatitis C and survival after renal transplant JO - J Viral Hepat VL - 21 UR - https://doi.org/10.1111/jvh.12148 DO - 10.1111/jvh.12148 ID - Fabrizi2014 ER - TY - JOUR AU - Mathurin, P. AU - Mouquet, C. AU - Poynard, T. AU - Sylla, C. AU - Benalia, H. AU - Fretz, C. PY - 1999 DA - 1999// TI - Impact of hepatitis B and C virus on kidney transplantation outcome JO - Hepatology VL - 29 UR - https://doi.org/10.1002/hep.510290123 DO - 10.1002/hep.510290123 ID - Mathurin1999 ER - TY - JOUR AU - Bruchfeld, A. AU - Wilczek, H. AU - Elinder, C. G. PY - 2004 DA - 2004// TI - Hepatitis C infection, time in renal-replacement therapy, and outcome after kidney transplantation JO - Transplantation VL - 78 UR - https://doi.org/10.1097/01.TP.0000131948.29742.24 DO - 10.1097/01.TP.0000131948.29742.24 ID - Bruchfeld2004 ER - TY - JOUR AU - Baid-Agrawal, S. AU - Pascual, M. AU - Moradpour, D. AU - Somasundaram, R. AU - Muche, M. PY - 2014 DA - 2014// TI - Hepatitis C virus infection and kidney transplantation in 2014: what's new? JO - Am J Transplant VL - 14 UR - https://doi.org/10.1111/ajt.12835 DO - 10.1111/ajt.12835 ID - Baid-Agrawal2014 ER - TY - JOUR AU - Terrault, N. A. AU - Adey, D. B. PY - 2007 DA - 2007// TI - The kidney transplant recipient with hepatitis C infection: pre- and posttransplantation treatment JO - Clin J Am Soc Nephrol VL - 2 UR - https://doi.org/10.2215/CJN.02930806 DO - 10.2215/CJN.02930806 ID - Terrault2007 ER - TY - JOUR AU - Fabrizi, F. AU - Dixit, V. AU - Messa, P. PY - 2012 DA - 2012// TI - Impact of hepatitis C on survival in dialysis patients: a link with cardiovascular mortality? JO - J Viral Hepat VL - 19 UR - https://doi.org/10.1111/j.1365-2893.2012.01633.x DO - 10.1111/j.1365-2893.2012.01633.x ID - Fabrizi2012 ER - TY - JOUR AU - Lee, M. H. AU - Yang, H. I. AU - Lu, S. N. AU - Jen, C. L. AU - You, S. L. AU - Wang, L. Y. PY - 2012 DA - 2012// TI - Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: a community-based long-term prospective study JO - J Infect Dis VL - 206 UR - https://doi.org/10.1093/infdis/jis385 DO - 10.1093/infdis/jis385 ID - Lee2012 ER - TY - JOUR AU - Manns, M. P. AU - McHutchison, J. G. AU - Gordon, S. C. AU - Rustgi, V. K. AU - Shiffman, M. AU - Reindollar, R. PY - 2001 DA - 2001// TI - Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial JO - Lancet VL - 358 UR - https://doi.org/10.1016/S0140-6736(01)06102-5 DO - 10.1016/S0140-6736(01)06102-5 ID - Manns2001 ER - TY - JOUR AU - Sawinski, D. AU - Bloom, R. D. PY - 2015 DA - 2015// TI - Novel hepatitis C treatment and the impact on kidney transplantation JO - Transplantation VL - 99 UR - https://doi.org/10.1097/TP.0000000000000847 DO - 10.1097/TP.0000000000000847 ID - Sawinski2015 ER - TY - JOUR AU - Poordad, F. AU - McCone, J. AU - Bacon, B. R. AU - Bruno, S. AU - Manns, M. P. AU - Sulkowski, M. S. PY - 2011 DA - 2011// TI - Boceprevir for untreated chronic HCV genotype 1 infection JO - N Engl J Med VL - 364 UR - https://doi.org/10.1056/NEJMoa1010494 DO - 10.1056/NEJMoa1010494 ID - Poordad2011 ER - TY - JOUR AU - Jacobson, I. M. AU - McHutchison, J. G. AU - Dusheiko, G. AU - Bisceglie, A. M. AU - Reddy, K. R. AU - Bzowej, N. H. PY - 2011 DA - 2011// TI - Telaprevir for previously untreated chronic hepatitis C virus infection JO - N Engl J Med VL - 364 UR - https://doi.org/10.1056/NEJMoa1012912 DO - 10.1056/NEJMoa1012912 ID - Jacobson2011 ER - TY - JOUR AU - Kulkarni, S. AU - Kirkiles-Smith, N. C. AU - Deng, Y. H. AU - Formica, R. N. AU - Moeckel, G. AU - Broecker, V. PY - 2017 DA - 2017// TI - Eculizumab therapy for Chronic antibody-mediated injury in kidney transplant recipients: a pilot randomized controlled trial JO - Am J Transplant VL - 17 UR - https://doi.org/10.1111/ajt.14001 DO - 10.1111/ajt.14001 ID - Kulkarni2017 ER - TY - JOUR AU - Gehring, S. AU - Gregory, S. H. AU - Wintermeyer, P. AU - Aloman, C. AU - Wands, J. R. PY - 2009 DA - 2009// TI - Generation of immune responses against hepatitis C virus by dendritic cells containing NS5 protein-coated microparticles JO - Clin Vaccine Immunol VL - 16 UR - https://doi.org/10.1128/CVI.00287-08 DO - 10.1128/CVI.00287-08 ID - Gehring2009 ER - TY - JOUR AU - Nelson, D. R. AU - Cooper, J. N. AU - Lalezari, J. P. AU - Lawitz, E. AU - Pockros, P. J. AU - Gitlin, N. PY - 2015 DA - 2015// TI - All-oral 12-week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY-3 phase III study JO - Hepatology VL - 61 UR - https://doi.org/10.1002/hep.27726 DO - 10.1002/hep.27726 ID - Nelson2015 ER - TY - JOUR AU - Sulkowski, M. S. AU - Gardiner, D. F. AU - Rodriguez-Torres, M. AU - Reddy, K. R. AU - Hassanein, T. AU - Jacobson, I. PY - 2014 DA - 2014// TI - Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection JO - N Engl J Med VL - 370 UR - https://doi.org/10.1056/NEJMoa1306218 DO - 10.1056/NEJMoa1306218 ID - Sulkowski2014 ER - TY - JOUR AU - Leroy, V. AU - Angus, P. AU - Bronowicki, J. P. AU - Dore, G. J. AU - Hezode, C. AU - Pianko, S. PY - 2016 DA - 2016// TI - Daclatasvir, sofosbuvir, and ribavirin for hepatitis C virus genotype 3 and advanced liver disease: a randomized phase III study (ALLY-3+) JO - Hepatology VL - 63 UR - https://doi.org/10.1002/hep.28473 DO - 10.1002/hep.28473 ID - Leroy2016 ER - TY - JOUR AU - Luetkemeyer, A. F. AU - McDonald, C. AU - Ramgopal, M. AU - Noviello, S. AU - Bhore, R. AU - Ackerman, P. PY - 2016 DA - 2016// TI - 12 weeks of Daclatasvir in combination with Sofosbuvir for HIV-HCV coinfection (ALLY-2 study): efficacy and safety by HIV combination antiretroviral regimens JO - Clin Infect Dis VL - 62 UR - https://doi.org/10.1093/cid/ciw163 DO - 10.1093/cid/ciw163 ID - Luetkemeyer2016 ER - TY - JOUR AU - Sawinski, D. AU - Kaur, N. AU - Ajeti, A. AU - Trofe-Clark, J. AU - Lim, M. AU - Bleicher, M. PY - 2016 DA - 2016// TI - Successful treatment of hepatitis C in renal transplant recipients with direct-acting antiviral agents JO - Am J Transplant VL - 16 UR - https://doi.org/10.1111/ajt.13620 DO - 10.1111/ajt.13620 ID - Sawinski2016 ER - TY - JOUR AU - Kamar, N. AU - Marion, O. AU - Rostaing, L. AU - Cointault, O. AU - Ribes, D. AU - Lavayssiere, L. PY - 2016 DA - 2016// TI - Efficacy and safety of Sofosbuvir-based antiviral therapy to treat hepatitis C virus infection after kidney transplantation JO - Am J Transplant VL - 16 UR - https://doi.org/10.1111/ajt.13518 DO - 10.1111/ajt.13518 ID - Kamar2016 ER - TY - STD TI - Eisenberger U, Guberina H, Willuweit K, Bienholz A, Kribben A, Gerken G, et al. Successful treatment of chronic hepatitis C virus infection with sofosbuvir and ledipasvir in renal transplant recipients. Transplantation. 2017;101(5):980–6. https://doi.org/10.1097/TP.0000000000001414. ID - ref20 ER - TY - JOUR AU - Fernandez, I. AU - Munoz-Gomez, R. AU - Pascasio, J. M. AU - Baliellas, C. AU - Polanco, N. AU - Esforzado, N. PY - 2017 DA - 2017// TI - Efficacy and tolerability of interferon-free antiviral therapy in kidney transplant recipients with chronic hepatitis C JO - J Hepatol VL - 66 UR - https://doi.org/10.1016/j.jhep.2016.12.020 DO - 10.1016/j.jhep.2016.12.020 ID - Fernandez2017 ER - TY - JOUR AU - Colombo, M. AU - Aghemo, A. AU - Liu, H. AU - Zhang, J. AU - Dvory-Sobol, H. AU - Hyland, R. PY - 2017 DA - 2017// TI - Treatment with Ledipasvir-Sofosbuvir for 12 or 24 weeks in kidney transplant recipients with Chronic hepatitis C virus genotype 1 or 4 infection: a randomized trial JO - Ann Intern Med VL - 166 UR - https://doi.org/10.7326/M16-1205 DO - 10.7326/M16-1205 ID - Colombo2017 ER - TY - JOUR AU - Levey, A. S. AU - Stevens, L. A. AU - Schmid, C. H. AU - Zhang, Y. L. AU - Castro, A. F. AU - Feldman, H. I. PY - 2009 DA - 2009// TI - A new equation to estimate glomerular filtration rate JO - Ann Intern Med VL - 150 UR - https://doi.org/10.7326/0003-4819-150-9-200905050-00006 DO - 10.7326/0003-4819-150-9-200905050-00006 ID - Levey2009 ER - TY - JOUR AU - Hasin, D. AU - Hatzenbuehler, M. L. AU - Keyes, K. AU - Ogburn, E. PY - 2006 DA - 2006// TI - Substance use disorders: diagnostic and statistical manual of mental disorders, fourth edition (DSM-IV) and international classification of diseases, tenth edition (ICD-10) JO - Addiction VL - 101 UR - https://doi.org/10.1111/j.1360-0443.2006.01584.x DO - 10.1111/j.1360-0443.2006.01584.x ID - Hasin2006 ER - TY - JOUR AU - Loupy, A. AU - Haas, M. AU - Solez, K. AU - Racusen, L. AU - Glotz, D. AU - Seron, D. PY - 2017 DA - 2017// TI - The Banff 2015 kidney meeting report: current challenges in rejection classification and prospects for adopting molecular pathology JO - Am J Transplant VL - 17 UR - https://doi.org/10.1111/ajt.14107 DO - 10.1111/ajt.14107 ID - Loupy2017 ER - TY - JOUR AU - Sharif, A. AU - Hecking, M. AU - Vries, A. P. AU - Porrini, E. AU - Hornum, M. AU - Rasoul-Rockenschaub, S. PY - 2014 DA - 2014// TI - Proceedings from an international consensus meeting on posttransplantation diabetes mellitus: recommendations and future directions JO - Am J Transplant VL - 14 UR - https://doi.org/10.1111/ajt.12850 DO - 10.1111/ajt.12850 ID - Sharif2014 ER - TY - JOUR AU - Levy, J. C. AU - Matthews, D. R. AU - Hermans, M. P. PY - 1998 DA - 1998// TI - Correct homeostasis model assessment (HOMA) evaluation uses the computer program JO - Diabetes Care VL - 21 UR - https://doi.org/10.2337/diacare.21.12.2191 DO - 10.2337/diacare.21.12.2191 ID - Levy1998 ER - TY - JOUR AU - Gupta, S. AU - Wallace, M. J. AU - Cardella, J. F. AU - Kundu, S. AU - Miller, D. L. AU - Rose, S. C. PY - 2010 DA - 2010// TI - Quality improvement guidelines for percutaneous needle biopsy JO - J Vasc Interv Radiol VL - 21 UR - https://doi.org/10.1016/j.jvir.2010.01.011 DO - 10.1016/j.jvir.2010.01.011 ID - Gupta2010 ER - TY - JOUR AU - Batts, K. P. AU - Ludwig, J. PY - 1995 DA - 1995// TI - Chronic hepatitis. An update on terminology and reporting JO - Am J Surg Pathol VL - 19 UR - https://doi.org/10.1097/00000478-199512000-00007 DO - 10.1097/00000478-199512000-00007 ID - Batts1995 ER - TY - JOUR AU - Scheuer, P. J. PY - 1991 DA - 1991// TI - Classification of chronic viral hepatitis: a need for reassessment JO - J Hepatol VL - 13 UR - https://doi.org/10.1016/0168-8278(91)90084-O DO - 10.1016/0168-8278(91)90084-O ID - Scheuer1991 ER - TY - JOUR AU - Wai, C. T. AU - Greenson, J. K. AU - Fontana, R. J. AU - Kalbfleisch, J. D. AU - Marrero, J. A. AU - Conjeevaram, H. S. PY - 2003 DA - 2003// TI - A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C JO - Hepatology VL - 38 UR - https://doi.org/10.1053/jhep.2003.50346 DO - 10.1053/jhep.2003.50346 ID - Wai2003 ER - TY - JOUR AU - Andres-Otero, M. J. AU - De-Blas-Giral, I. AU - Puente-Lanzarote, J. J. AU - Serrano-Aullo, T. AU - Morandeira, M. J. AU - Lorente, S. PY - 2016 DA - 2016// TI - Multiple approaches to assess fourteen non-invasive serum indexes for the diagnosis of liver fibrosis in chronic hepatitis C patients JO - Clin Biochem VL - 49 UR - https://doi.org/10.1016/j.clinbiochem.2015.12.017 DO - 10.1016/j.clinbiochem.2015.12.017 ID - Andres-Otero2016 ER - TY - JOUR AU - Sterling, R. K. AU - Lissen, E. AU - Clumeck, N. AU - Sola, R. AU - Correa, M. C. AU - Montaner, J. PY - 2006 DA - 2006// TI - Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection JO - Hepatology VL - 43 UR - https://doi.org/10.1002/hep.21178 DO - 10.1002/hep.21178 ID - Sterling2006 ER - TY - JOUR AU - Bourliere, M. AU - Gordon, S. C. AU - Flamm, S. L. AU - Cooper, C. L. AU - Ramji, A. AU - Tong, M. PY - 2017 DA - 2017// TI - Sofosbuvir, Velpatasvir, and Voxilaprevir for previously treated HCV infection JO - N Engl J Med VL - 376 UR - https://doi.org/10.1056/NEJMoa1613512 DO - 10.1056/NEJMoa1613512 ID - Bourliere2017 ER - TY - JOUR AU - Hirotsu, Y. AU - Kanda, T. AU - Matsumura, H. AU - Moriyama, M. AU - Yokosuka, O. AU - Omata, M. PY - 2015 DA - 2015// TI - HCV NS5A resistance-associated variants in a group of real-world Japanese patients chronically infected with HCV genotype 1b JO - Hepatol Int VL - 9 UR - https://doi.org/10.1007/s12072-015-9624-2 DO - 10.1007/s12072-015-9624-2 ID - Hirotsu2015 ER - TY - JOUR AU - Lubetzky, M. AU - Chun, S. AU - Joelson, A. AU - Coco, M. AU - Kamal, L. AU - Ajaimy, M. PY - 2017 DA - 2017// TI - Safety and efficacy of treatment of hepatitis C in kidney transplant recipients with directly acting antiviral agents JO - Transplantation VL - 101 UR - https://doi.org/10.1097/TP.0000000000001618 DO - 10.1097/TP.0000000000001618 ID - Lubetzky2017 ER - TY - JOUR AU - Eisenberger, U. AU - Guberina, H. AU - Willuweit, K. AU - Bienholz, A. AU - Kribben, A. AU - Gerken, G. PY - 2017 DA - 2017// TI - Successful treatment of Chronic hepatitis C virus infection with Sofosbuvir and Ledipasvir in renal transplant recipients JO - Transplantation VL - 101 UR - https://doi.org/10.1097/TP.0000000000001414 DO - 10.1097/TP.0000000000001414 ID - Eisenberger2017 ER - TY - JOUR AU - Siederdissen, C. H. Z. AU - Maasoumy, B. AU - Marra, F. AU - Deterding, K. AU - Port, K. AU - Manns, M. P. PY - 2016 DA - 2016// TI - Drug-drug interactions with novel all Oral interferon-free antiviral agents in a large real-world cohort JO - Clin Infect Dis VL - 62 UR - https://doi.org/10.1093/cid/civ973 DO - 10.1093/cid/civ973 ID - Siederdissen2016 ER - TY - JOUR AU - Fujita, N. AU - Sugimoto, R. AU - Takeo, M. AU - Urawa, N. AU - Mifuji, R. AU - Tanaka, H. PY - 2007 DA - 2007// TI - Hepcidin expression in the liver: relatively low level in patients with chronic hepatitis C JO - Mol Med VL - 13 ID - Fujita2007 ER - TY - JOUR AU - Arcaini, L. AU - Vallisa, D. AU - Rattotti, S. AU - Ferretti, V. V. AU - Ferreri, A. J. AU - Bernuzzi, P. PY - 2014 DA - 2014// TI - Antiviral treatment in patients with indolent B-cell lymphomas associated with HCV infection: a study of the Fondazione Italiana Linfomi JO - Ann Oncol VL - 25 UR - https://doi.org/10.1093/annonc/mdu166 DO - 10.1093/annonc/mdu166 ID - Arcaini2014 ER - TY - JOUR AU - Visentini, M. AU - Fiorilli, M. AU - Casato, M. PY - 2017 DA - 2017// TI - From the pathogenesis to the cure of indolent B-cell lymphoproliferative disorders associated with hepatitis C virus infection: which role for direct-acting antivirals? JO - Expert Rev Hematol VL - 10 UR - https://doi.org/10.1080/17474086.2017.1349607 DO - 10.1080/17474086.2017.1349607 ID - Visentini2017 ER - TY - JOUR AU - Kralj, D. AU - Virovic Jukic, L. AU - Stojsavljevic, S. AU - Duvnjak, M. AU - Smolic, M. AU - Curcic, I. B. PY - 2016 DA - 2016// TI - Hepatitis C virus, insulin resistance, and steatosis JO - J Clin Transl Hepatol VL - 4 UR - https://doi.org/10.14218/JCTH.2015.00051 DO - 10.14218/JCTH.2015.00051 ID - Kralj2016 ER - TY - JOUR AU - Kawaguchi, T. AU - Ide, T. AU - Taniguchi, E. AU - Hirano, E. AU - Itou, M. AU - Sumie, S. PY - 2007 DA - 2007// TI - Clearance of HCV improves insulin resistance, beta-cell function, and hepatic expression of insulin receptor substrate 1 and 2 JO - Am J Gastroenterol VL - 102 UR - https://doi.org/10.1111/j.1572-0241.2006.01038.x DO - 10.1111/j.1572-0241.2006.01038.x ID - Kawaguchi2007 ER - TY - JOUR AU - Aytaman, A. AU - McFarlane, S. I. PY - 2008 DA - 2008// TI - Uncovering glucose abnormalities in people with hepatitis C infection: should oral glucose tolerance test become a standard of care? JO - Am J Gastroenterol VL - 103 UR - https://doi.org/10.1111/j.1572-0241.2008.02007.x DO - 10.1111/j.1572-0241.2008.02007.x ID - Aytaman2008 ER - TY - JOUR AU - Goldberg, D. S. AU - Abt, P. L. AU - Reese, P. P. PY - 2017 DA - 2017// TI - Transplanting HCV-infected kidneys into uninfected recipients JO - N Engl J Med VL - 377 ID - Goldberg2017 ER -